Phase 2 BRACELET-1 study to evaluate Oncolytics' systemically delivered oncolytic virus, pelareorep, in combination with paclitaxel and anti-PD-L1 antibody avelumab…
ANGLE plc ("the Company") SUCCESSFUL COMPLETION OF OVARIAN CANCER PRE-STUDY Pre-study demonstrates ANGLE's optimised sample-to-answer molecular solution with patient samples…
LONDON, UK / ACCESSWIRE / June 5, 2019 / Hemogenyx Pharmaceuticals plc (LSE: HEMO) announces the first data results from…
INCLUDING NEW CELL TYPES SUPPORTS DISCOVERY OF DISEASE-MODIFYING THERAPIES FOR NEURODEGENERATIVE DISEASES TRIGGERS $ 9.0 M PAYMENT TO EVOTEC HAMBURG,…
LOS ANGELES, CA / ACCESSWIRE / June 4, 2019 / NervGen Pharma Corp. (TSX-V: NGEN) (OTCQB: NGENF), a regenerative medicine…
Annual Awards Program Recognizes Outstanding Digital Health & Medical Technology Products and CompaniesASHTEAD, UK – June 4, 2019 – BridgeHead…
LIVINGSTON, NJ / ACCESSWIRE / June 4, 2019 / Milestone Scientific Inc. (NYSE American: MLSS) today announced that the shares…
Initial Purchase by Beijing Dahua Sanxin Technology Development Co., Ltd. Represents First MiOXSYS Commercial Sale in China. ENGLEWOOD, CO /…
SAN CLEMENTE, CA / ACCESSWIRE / June 4, 2019 / ReShape Lifesciences Inc. (OTCQB: RSLS), a developer of minimally invasive…
Expands Market Presence in Asia Pacific Region REDWOOD CITY, CA / ACCESSWIRE / June 4, 2019 / Avinger, Inc. (NASDAQ:…
ARQ-151 Potential "Best in Class" Topical PDE4 inhibitor ARQ-151 is 50- to 300-fold more potent than approved PDE4 inhibitors Phase…
Designed and Engineered to Speed Surgery and Provide Patient Optimized Fit WEST PALM BEACH, FL / ACCESSWIRE / June 3,…
A double board-certified Anesthesiologist, Dr. Nikesh Seth is also CEO of Integrated Pain Consultants with three locations in Arizona; Consistently…
- Combination of nanoparticle CBD-infused patch/cream and PainShield® intended as powerful alternative to opioids for treatment of pain - NanoVibronix…
ST. PETERSBURG, FL / ACCESSWIRE / June 3, 2019 / Medical Research Collaborative, LLC (MRC) announces the recent launch of…
20-Year Global Commercial Medical Imaging Veteran to Lead Rollout of ENDRA Technology in European and U.S. Markets ANN ARBOR, MI…
MALVERN, PA / ACCESSWIRE / June 3, 2019 / Virpax® Pharmaceuticals, Inc. ("Virpax"), a company specializing in developing pharmaceutical products…
SAN FRANCISCO, CA / ACCESSWIRE / June 3, 2019 / Jaguar Health, Inc. (NASDAQ: JAGX) ("Jaguar" or the "Company"), a…
Clinical benefit observed in 55% of patients receiving HS-110 plus nivolumab after checkpoint inhibitor treatment failureHS-110 in combination with nivolumab…
WALTHAM, MA / ACCESSWIRE / June 3, 2019 / EyeGate Pharmaceuticals, Inc. (NASDAQ: EYEG) ("EyeGate" or "the Company") announced today…